The Boston, Massachusetts – based synthetic biology company, known in the beauty industry for its work with fragrance maker Robertet, has just announced $275 million in Series D funding and the opening of a new facility that promises to launch the company...
Today the companies announced a deal that will put advanced automation software to work in a new way at Gingko’s synthetic biology foundry and, in doing so, significantly scale its output capacity by 2022.
In recent days the biotech company has announced deals with two enzyme producing businesses. While the bulk of what these companies develop and make will be directed to the food industry, there are implications and opportunities here for cosmetics and...
Robertet and Ginkgo Bioworks collaborated on a production strategy, using designer yeast, that can now create fragrance notes at a scale sufficient to meet the needs of the cosmetics, perfume, and personal care industry.
The biotech company will have new tech tools, thanks to this deal, and as a result be able to expand its bio-engineering capabilities for clients in fragrance, cosmetics, and beyond.
As September came to a close, Ginkgo opened a facility that changes the scale and scope of biotech ingredient and organism production exponentially. And, it’s at sites like this where tomorrow’s genetically engineered inputs for fragrance, cosmetics,...
Biotech innovations require industry-scale resources to get alternative ingredients for fragrance and personal care to market. As that market grows, synthetic DNA manufacturing, like what Twist Bioscience does, is in greater demand.
The Boston, Massachusetts–based organism engineering company announced today that it has entered into a multi-million dollar contract extending its partnership with fragrance maker Robertet.
